Literature DB >> 21075352

Mouse STAT2 restricts early dengue virus replication.

Joseph Ashour1, Juliet Morrison, Maudry Laurent-Rolle, Alan Belicha-Villanueva, Courtney Ray Plumlee, Dabeiba Bernal-Rubio, Katherine L Williams, Eva Harris, Ana Fernandez-Sesma, Christian Schindler, Adolfo García-Sastre.   

Abstract

Dengue virus encodes several interferon antagonists. Among these the NS5 protein binds STAT2, a necessary component of the type I interferon signaling pathway, and targets it for degradation. We now demonstrate that the ability of dengue NS5 to associate with and degrade STAT2 is species specific. Thus, NS5 is able to bind and degrade human STAT2, but not mouse STAT2. This difference was exploited to demonstrate, absent manipulation of the viral genome, that NS5-mediated IFN antagonism is essential for efficient virus replication. Moreover, we demonstrate that differences in NS5 mediated binding and degradation between human and mouse STAT2 maps to a region within the STAT2 coiled-coil domain. By using STAT2(-/-) mice, we also demonstrate that mouse STAT2 restricts early dengue virus replication in vivo. These results suggest that overcoming this restriction through transgenic mouse technology may help in the development of a long-sought immune-competent mouse model of dengue virus infection.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21075352      PMCID: PMC3310429          DOI: 10.1016/j.chom.2010.10.007

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  70 in total

1.  Nucleotide and complete amino acid sequences of Kunjin virus: definitive gene order and characteristics of the virus-specified proteins.

Authors:  G Coia; M D Parker; G Speight; M E Byrne; E G Westaway
Journal:  J Gen Virol       Date:  1988-01       Impact factor: 3.891

2.  Two interferon-induced nuclear factors bind a single promoter element in interferon-stimulated genes.

Authors:  D S Kessler; D E Levy; J E Darnell
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

3.  Degradation of STAT1 and STAT2 by the V proteins of simian virus 5 and human parainfluenza virus type 2, respectively: consequences for virus replication in the presence of alpha/beta and gamma interferons.

Authors:  J Andrejeva; D F Young; S Goodbourn; R E Randall
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

4.  Inhibition of the type I interferon response in human dendritic cells by dengue virus infection requires a catalytically active NS2B3 complex.

Authors:  Juan R Rodriguez-Madoz; Alan Belicha-Villanueva; Dabeiba Bernal-Rubio; Joseph Ashour; Juan Ayllon; Ana Fernandez-Sesma
Journal:  J Virol       Date:  2010-07-21       Impact factor: 5.103

5.  Genetic basis of attenuation of dengue virus type 4 small plaque mutants with restricted replication in suckling mice and in SCID mice transplanted with human liver cells.

Authors:  Joseph E Blaney; Daniel H Johnson; Gracielle G Manipon; Cai-Yen Firestone; Christopher T Hanson; Brian R Murphy; Stephen S Whitehead
Journal:  Virology       Date:  2002-08-15       Impact factor: 3.616

6.  Replication-deficient ebolavirus as a vaccine candidate.

Authors:  Peter Halfmann; Hideki Ebihara; Andrea Marzi; Yasuko Hatta; Shinji Watanabe; M Suresh; Gabriele Neumann; Heinz Feldmann; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

7.  Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification.

Authors:  Scott J Balsitis; Katherine L Williams; Ruben Lachica; Diana Flores; Jennifer L Kyle; Erin Mehlhop; Syd Johnson; Michael S Diamond; P Robert Beatty; Eva Harris
Journal:  PLoS Pathog       Date:  2010-02-12       Impact factor: 6.823

8.  NS5 of dengue virus mediates STAT2 binding and degradation.

Authors:  Joseph Ashour; Maudry Laurent-Rolle; Pei-Yong Shi; Adolfo García-Sastre
Journal:  J Virol       Date:  2009-03-11       Impact factor: 5.103

9.  Dengue virus NS5 inhibits interferon-alpha signaling by blocking signal transducer and activator of transcription 2 phosphorylation.

Authors:  Michela Mazzon; Meleri Jones; Andrew Davidson; Benjamin Chain; Michael Jacobs
Journal:  J Infect Dis       Date:  2009-10-15       Impact factor: 5.226

10.  Comparative analysis of the immunogenicity of SARS-CoV nucleocapsid DNA vaccine administrated with different routes in mouse model.

Authors:  Hui Hu; Xianqing Huang; Ling Tao; Yi Huang; Bao-An Cui; Hanzhong Wang
Journal:  Vaccine       Date:  2009-01-30       Impact factor: 3.641

View more
  100 in total

1.  Type 1 IFN-independent activation of a subset of interferon stimulated genes in West Nile virus Eg101-infected mouse cells.

Authors:  Joanna A Pulit-Penaloza; Svetlana V Scherbik; Margo A Brinton
Journal:  Virology       Date:  2012-02-03       Impact factor: 3.616

Review 2.  Comparative mapping of host-pathogen protein-protein interactions.

Authors:  Priya S Shah; Jason A Wojcechowskyj; Manon Eckhardt; Nevan J Krogan
Journal:  Curr Opin Microbiol       Date:  2015-08-10       Impact factor: 7.934

Review 3.  The role of signal transducer and activator of transcription-2 in the interferon response.

Authors:  Håkan C Steen; Ana M Gamero
Journal:  J Interferon Cytokine Res       Date:  2012-01-26       Impact factor: 2.607

Review 4.  Barriers to preclinical investigations of anti-dengue immunity and dengue pathogenesis.

Authors:  Ashley L St John; Soman N Abraham; Duane J Gubler
Journal:  Nat Rev Microbiol       Date:  2013-05-08       Impact factor: 60.633

5.  Disruption of type I interferon signaling by the nonstructural protein of severe fever with thrombocytopenia syndrome virus via the hijacking of STAT2 and STAT1 into inclusion bodies.

Authors:  Yun-Jia Ning; Kuan Feng; Yuan-Qin Min; Wu-Chun Cao; Manli Wang; Fei Deng; Zhihong Hu; Hualin Wang
Journal:  J Virol       Date:  2015-01-28       Impact factor: 5.103

Review 6.  Mouse models of dengue virus infection for vaccine testing.

Authors:  Vanessa V Sarathy; Gregg N Milligan; Nigel Bourne; Alan D T Barrett
Journal:  Vaccine       Date:  2015-10-23       Impact factor: 3.641

Review 7.  Structure and function of Zika virus NS5 protein: perspectives for drug design.

Authors:  Boxiao Wang; Stephanie Thurmond; Rong Hai; Jikui Song
Journal:  Cell Mol Life Sci       Date:  2018-02-08       Impact factor: 9.261

Review 8.  Dengue Virus Control of Type I IFN Responses: A History of Manipulation and Control.

Authors:  Jorge Andrés Castillo Ramirez; Silvio Urcuqui-Inchima
Journal:  J Interferon Cytokine Res       Date:  2015-01-28       Impact factor: 2.607

9.  Genetic manipulation of the ApoF/Stat2 locus supports an important role for type I interferon signaling in atherosclerosis.

Authors:  William R Lagor; David W Fields; Robert C Bauer; Alison Crawford; Michael C Abt; David Artis; E John Wherry; Daniel J Rader
Journal:  Atherosclerosis       Date:  2014-01-10       Impact factor: 5.162

10.  Increased early RNA replication by chimeric West Nile virus W956IC leads to IPS-1-mediated activation of NF-κB and insufficient virus-mediated counteraction of the resulting canonical type I interferon signaling.

Authors:  S V Scherbik; J A Pulit-Penaloza; M Basu; S C Courtney; M A Brinton
Journal:  J Virol       Date:  2013-05-15       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.